Yüklüyor......
Exploring N(1)-p-Fluorobenzyl-Cymserine as an Inhibitor of 5-Lipoxygenase as a Candidate for Type 2 Diabetes and Neurodegenerative Disorder Treatment
Developing a single selective ligand to a target relevant to two mechanistically interlinked diseases, such as type 2 diabetes mellitus (T2DM) and a neurodegenerative disorder, like Parkinson's disease or Alzheimer's disease, provides the potential for an effective treatment that may impac...
Kaydedildi:
| Yayımlandı: | CNS Neurol Disord Drug Targets |
|---|---|
| Asıl Yazarlar: | , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
2014
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4807432/ https://ncbi.nlm.nih.gov/pubmed/24059322 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|